Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
ECOR vs HSDT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HSDT Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 8–1 Matrix Metrics)
HSDT Overall Winner
6-Pillar Tally: ECOR 2 – 3 HSDT (1 Tie)
Matrix Metrics: ECOR 1 – 8 HSDT
As of Nov 19, 2026, Solana Company (HSDT) is the stronger overall head-to-head candidate over electroCore, Inc. (ECOR) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ECOR carries a Unified Composite Score of 56.8/100 (HOLD) at $4.85 (N/M Forward P/E, -33.1% operating margin), whereas HSDT carries 59.0/100 (HOLD) at $1.66 (N/M Forward P/E, -1557.5% operating margin).
- Technical & Structure Timing Caution: ECOR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.5); meanwhile HSDT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About ECOR vs HSDT
ECOR
electroCore, Inc. Common Stock
$4.85
-6.19% 1D
Market Cap
$47.7M
TTM Revenue
$38M
Forward P/E
N/M
Beta / 30D Vol
1.52β · 155% Vol
Unified Composite Score
56.8
HOLD
Tech 68.0
Fund 53.0
Flow 50.0
Mom 64.0
Weinstein Technical Phase
Markdown · Sell / avoid
HSDT
Head-to-Head Winner
Solana Company Class A Common Stock (DE)
$1.66
+1.84% 1D
Market Cap
$103.1M
TTM Revenue
$272M
Forward P/E
N/M
Beta / 30D Vol
2.20β · 55% Vol
Unified Composite Score
59.0
HOLD
Tech 60.0
Fund 53.0
Flow 58.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (ECOR 2 – 3 HSDT)
1. Valuation Multiples
HSDT
Forward P/E
N/M
N/M
Trailing P/E
N/M
0.0x
PEG Ratio
N/M
N/M
EV / Revenue
1.4x
0.4x
2. Growth & Scale
HSDT
Revenue Growth (YoY)
+11.5%
+382.1%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$38M
$272M
Market Cap
$47.7M
$103.1M
3. Profitability & Quality
HSDT
Gross Margin
87.7%
92.8%
Operating Margin
-33.1%
-1557.5%
Net Profit Margin
-33.5%
2040.4%
Return on Equity (ROE)
-478.7%
52.8%
4. Balance Sheet & Cash Flow
ECOR
Cash Generation (TTM)
-$6.9M
-$4.22B EBITDA
Cash Flow Margin
-18.1%
N/A
Net Cash / Leverage
$4.6M Net Debt
$4.38 Book/Sh · 52.8% ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
ECOR
Options Structure Phase
UNCLASSIFIED
BREAKDOWN
Current IV / %ile
N/A (N/A)
540.7% (85th %ile)
Put/Call OI Skew
N/A
7.50x (Put-Skewed)
OBV Trend / Tech Phase
NEUTRAL · Markdown
DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
High-Margin Pricing Power Moat
Supply-Chain Role
Medical Devices Operator
Asset Management Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: ECOR (1) vs HSDT (8)| Institutional Metric | ECOR | HSDT | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $47.7M | $103.1M | HSDT | |
| Trailing P/E Ratio | N/M | 0.0x | HSDT | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | +11.5% | +382.1% | HSDT | |
| Operating Margin (TTM) | -33.1% | -1557.5% | ECOR | |
| Net Profit Margin | -33.5% | 2040.4% | HSDT | |
| Return on Equity (ROE) | -478.7% | 52.8% | HSDT | |
| 52-Week Range Position | 6% ($4–$13) | 15% ($1–$4) | HSDT | |
| Beta / 30D Volatility | 1.52β · 155% Vol | 2.20β · 55% Vol | HSDT | |
| Unified Institutional Score | 56.8 / 100 (HOLD) | 59.0 / 100 (HOLD) | HSDT | |
| Trailing 12M Revenue (USD) | $38M | $272M | Scale | |
| Gross Profit Margin (TTM) | 87.7% | 92.8% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 1.4x EV/Rev | N/M PEG · 0.4x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$6.9M ($4.6M Net Debt) | -$4.22B EBITDA ($4.38 Book/Sh · 52.8% ROE) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
HSDT +4.35 pp
3M Horizon
HSDT +32.95 pp
6M Horizon
ECOR +10.63 pp
1Y Horizon
ECOR +54.54 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ECOR Revenue | HSDT Revenue | ECOR Op. Margin | HSDT Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $0M | $0M | -5494.1% | -5580.5% | ECOR |
| FY2019 | $0M | $0M | -1928.2% | -1604.0% | HSDT |
| FY2020 | $0M | $0M | -707.9% | -2176.4% | ECOR |
| FY2021 | $10M | $0M | -367.7% | -3679.9% | ECOR |
| FY2022 | $10M | $0M | -266.2% | -1994.3% | ECOR |
| FY2023 | $20M | $0M | -120.2% | -2054.2% | ECOR |
| FY2024 | $30M | $0M | -48.3% | -2673.7% | ECOR |
| FY2025 | $30M | $0M | -41.1% | -44496.4% | ECOR |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
ECOR
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact ECOR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
HSDT
BREAKDOWN
Current IV
540.7%
IV Percentile
85th %ile
Put/Call OI Skew
7.50x (Put-Skewed)
IV Regime
Extreme (>80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact HSDT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
ECOR Moat Profile
Cyclical / Execution-Driven Positioning
Medical Devices Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
HSDT Moat Profile
High-Margin Pricing Power Moat
Asset Management Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ ECOR vs HSDT Key Questions & Quantitative Answers
As of Nov 19, 2026, Solana Company (HSDT) is the stronger overall head-to-head candidate over electroCore, Inc. (ECOR) in the Tradestie Institutional Equity Comparison Engine, winning 8–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ECOR carries a Unified Composite Score of 56.8/100 (HOLD) at $4.85 (N/M Forward P/E, -33.1% operating margin), whereas HSDT carries 59.0/100 (HOLD) at $1.66 (N/M Forward P/E, -1557.5% operating margin). Technical & Structure Timing Caution: ECOR is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 31.5); meanwhile HSDT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
HSDT leads the Growth & Scale pillar: ECOR posts +11.5% YoY revenue growth and +0.0% YoY earnings growth on $38M TTM revenue (87.7% gross margin, -33.1% operating margin), compared with HSDT at +382.1% YoY revenue growth and +0.0% YoY earnings growth on $272M TTM revenue (92.8% gross margin, -1557.5% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ECOR cumulative revenue shifted +200.0% while HSDT shifted N/A. In operating R&D and SG&A reinvestment, ECOR deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HSDT.
HSDT screens cheaper on headline valuation multiples. ECOR trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.4x EV/Revenue (-18.1% FCF margin), whereas HSDT trades at N/M Forward P/E, 0.0x Trailing P/E, N/M PEG, and 0.4x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ECOR (-478.7% ROE) versus HSDT (52.8% ROE) capital efficiency.
In options market volatility and institutional positioning, ECOR carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.52β · 155% Vol realized risk). By comparison, HSDT carries 540.7% implied volatility (85th %ile, Extreme (>80th %ile)), a 7.50x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.20β · 55% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
HSDT vs ECOR · Reverse Pair
ECOR vs PRPO
· Sector Peer
HSDT vs QNRX
· Sector Peer
HSDT vs NUWE
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking